ArticleBMC neurology2026

Switching from complement inhibitors in AQP4-IgG-positive NMOSD: clinical characteristics, an operational "cluster phase" and potential strategies to prevent therapeutic gaps.

Kenzo Sakurai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.